Ingrid Hogberg, MD
Cardiovascular Disease (Cardiology) · Fremont
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 1
- 1 carrier
- Offices
- 10
Offices
10 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Hospitals listed: Washington Hospital. That is not proof they admit you there this week.
Plans that list them
1 plan · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Hogberg’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A97154 · Current
Licensed to practise in California · since 2006 · expires 2028-01-31 · University of California, Davis School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Washington HospitalFremont, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of Washington Hospital Healthcare SystemPatients rate it 3 of 5 · 71% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.188, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.164, Oct 2024 – Sep 2025
See every measure and the patient survey for Washington Hospital
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 1 better, 6 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.188 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.164 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.88 (0 to 1.88) · 1,112 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.92 (0.59 to 1.24) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 192.95 (139.54 to 246.36) · 48 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2 · 27 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.4 · 164 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.1 · 199 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 463 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.6 · 661 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.3 · 174 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.7 · 2,550 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.15 (0 to 0.35) · 6,970 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,108 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.82 (1.73 to 5.91) · 1,370 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.52 (0 to 3.17) · 589 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.75 (0.25 to 3.25) · 1,315 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 13.19 (5.83 to 20.56) · 600 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.91 (1.04 to 8.78) · 550 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.66 (0.17 to 3.14) · 198 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.14 (0 to 0.78) · 6,079 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.7 · 114 cases | None | Apr 2023 – Mar 2025 |
| MRSA BacteremiaInfections | 0 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.367 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.8 · 186 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.9 · 480 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 33.9 · 186 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 26.5 · 553 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 36.8 · 648 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.5 · 590 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.7 (3.2 to 6.9) · 169 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.4 (8.5 to 14.9) · 169 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 130 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.1 · 41 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 202 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.7 (10.2 to 18.5) · 78 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.1) · 974 cases | No different | Jan 2024 – Dec 2024 |
What patients said (812 patients answered, 19% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 56% |
| Yes, staff "did" give patients this information | 84% |
| Yes, staff "did" give patients information about help after discharge | 84% |
| Doctors "always" explained things so they could understand | 70% |
| Doctors "always" listened carefully | 76% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 71% |
| Staff "always" explained new medications | 70% |
| Nurses "always" explained things so they could understand | 72% |
| Nurses "always" listened carefully | 74% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 46% |
| "YES", patients would definitely recommend the hospital | 71% |
| Staff "always" explained possible side effects | 42% |
| Yes, staff "did" give patients information about possible symptoms | 84% |
Original Medicare doctor bills
$211,696
Medicare paid this office $211,696 for 1,207 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 336 | $62,253 | $183 |
| Return visit (30+ min) | 260 | $41,916 | $113 |
| Long return visit (40+ min) | 132 | $27,841 | $163 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 98 | $22,445 | $227 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 25 | $11,592 | $464 |
See all 27 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 336 | $62,253 | $183 |
| Return visit (30+ min) | 260 | $41,916 | $113 |
| Long return visit (40+ min) | 132 | $27,841 | $163 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 98 | $22,445 | $227 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 25 | $11,592 | $464 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 400 | $5,249 | $12 |
| New patient visit (60+ min) | 22 | $4,171 | $190 |
| Heart muscle strain imaging | 106 | $4,091 | $38 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 21 | $3,548 | $154 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 24 | $3,497 | $70 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 51 | $3,042 | $60 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 171 | $2,738 | $15 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 95 | $2,169 | $22 |
| Injection, perflutren lipid microspheres, per ml | 45 | $2,073 | $32 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 25 | $1,576 | $63 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 19 | $1,300 | $68 |
| Ultrasound of heart, follow-up | 14 | $1,255 | $90 |
| 3d radiographic procedure | 48 | $1,205 | $25 |
| Heart rhythm recording of continous external ekg over 8-15 days | 91 | $1,112 | $12 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 34 | $863 | $25 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 17 | $832 | $29 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 26 | $684 | $26 |
| Injection of x-ray contrast during ultrasound of heart | 16 | $584 | $37 |
| Injection, regadenoson, 0.1 mg | 23 | $450 | None |
| Ambulatory blood pressure monitoring, 1 day or longer, with recording, scanning analysis, interpretation, and report | 11 | $410 | $37 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 25 | $350 | $7 |
| Injection, dobutamine hydrochloride, per 250 mg | 16 | $147 | None |
Who their Medicare patients are
1,207 Original Medicare patients in 2024. Average age 77 · Under 65 3% · 85 and older 18% · Women 55% · Also on Medicaid 20% · Health risk score 1.22. At or below the middle of the specialty; the typical cardiology clinician is at 1.71.
Conditions among them: High blood pressure 75% · Coronary heart disease 42% · Diabetes 36% · Atrial fibrillation 28% · Chronic kidney disease 27% · Heart failure 25% · Cancer 14% · Depression 14% · COPD 9% · Dementia 6% · Stroke 6%.
The office billed $1,020,719, Medicare allowed $284,385 and paid $211,696; for 2,580 services of 50 kinds; $3,001 of it was for drugs given in the office and $208,695 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 1,207 | 2,580 | 77 | 1.22 | $1,020,719 | $211,696 |
| 2023 | 1,126 | 2,215 | 77 | 1.23 | $889,289 | $194,709 |
| 2022 | 1,110 | 2,509 | 77 | 1.18 | $950,082 | $223,684 |
| 2021 | 1,132 | 2,677 | 76 | 1.21 | $940,609 | $229,738 |
| 2020 | 972 | 2,282 | 76 | 1.42 | $744,809 | $180,883 |
| 2019 | 1,215 | 2,821 | 77 | 1.46 | $987,474 | $235,837 |
| 2018 | 913 | 2,014 | 76 | 1.47 | $726,492 | $181,985 |
| 2017 | 1,236 | 2,347 | 76 | 1.34 | $854,668 | $222,923 |
| 2016 | 1,090 | 2,112 | 76 | 1.38 | $794,271 | $211,205 |
| 2015 | 714 | 1,338 | 76 | 1.32 | $626,181 | $186,831 |
| 2014 | 537 | 993 | 75 | 1.14 | $447,397 | $133,649 |
| 2013 | 215 | 460 | 78 | 1.11 | $86,165 | $37,498 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 26 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 258 | $47,230 | $180 |
| Return visit (30+ min) | 262 | $42,350 | $110 |
| Long return visit (40+ min) | 109 | $21,210 | $157 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 77 | $18,105 | $235 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 20 | $9,473 | $474 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 34 | $5,469 | $70 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 375 | $4,767 | $12 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 30 | $4,689 | $151 |
| New patient visit (60+ min) | 22 | $4,473 | $203 |
| Heart muscle strain imaging | 99 | $3,983 | $39 |
| Ultrasound of heart during rest, exercise and/or drug-induced stress with report | 20 | $3,637 | $182 |
| Injection, regadenoson, 0.1 mg | 15 | $2,661 | None |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 43 | $2,549 | $59 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 29 | $1,866 | $64 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 80 | $1,859 | $23 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 24 | $1,456 | $61 |
| Injection, perflutren lipid microspheres, per ml | 24 | $1,451 | $35 |
| 3d radiographic procedure | 42 | $1,042 | $25 |
| Heart rhythm recording of continous external ekg over 8-15 days | 80 | $1,000 | $12 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 33 | $794 | $24 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 14 | $711 | $30 |
| Ultrasound of heart blood flow, valves and chambers | 12 | $635 | $53 |
| Ambulatory blood pressure monitoring, 1 day or longer, with recording, scanning analysis, interpretation, and report | 15 | $528 | $35 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 20 | $475 | $12 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 16 | $372 | $23 |
| Injection, dobutamine hydrochloride, per 250 mg | 13 | $105 | None |
2022: 26 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 277 | $52,477 | $189 |
| Return visit (30+ min) | 249 | $38,944 | $109 |
| Long return visit (40+ min) | 123 | $25,054 | $159 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 31 | $14,320 | $448 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 30 | $14,059 | $234 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 38 | $8,391 | $221 |
| Heart muscle strain imaging | 200 | $8,049 | $40 |
| Injection, regadenoson, 0.1 mg | 32 | $6,153 | None |
| Ultrasound of heart during rest, exercise and/or drug-induced stress with report | 33 | $5,436 | $165 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 374 | $4,743 | $12 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 23 | $4,323 | $180 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 29 | $4,173 | $64 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 55 | $3,950 | $72 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 57 | $3,557 | $61 |
| 3d radiographic procedure | 129 | $3,009 | $23 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 41 | $2,454 | $60 |
| New patient visit (60+ min) | 13 | $2,409 | $185 |
| Injection, perflutren lipid microspheres, per ml | 34 | $2,359 | $36 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 74 | $1,842 | $24 |
| Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | 18 | $1,265 | $70 |
| Heart rhythm recording of continous external ekg over 8-15 days | 72 | $1,099 | $15 |
| Ambulatory blood pressure monitoring, 1 day or longer, with recording, scanning analysis, interpretation, and report | 16 | $700 | $44 |
| Administration of influenza virus vaccine | 19 | $697 | $37 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 16 | $413 | $26 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 14 | $302 | $20 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 13 | $168 | $13 |
2021: 27 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 252 | $49,618 | $192 |
| Return visit (30+ min) | 281 | $45,808 | $111 |
| Long return visit (40+ min) | 102 | $21,189 | $161 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 36 | $17,974 | $499 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 48 | $11,080 | $231 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 36 | $10,307 | $145 |
| Ultrasound of heart during rest, exercise and/or drug-induced stress with report | 35 | $6,491 | $185 |
| Injection, regadenoson, 0.1 mg | 34 | $6,470 | None |
| Heart muscle strain imaging | 142 | $6,122 | $42 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 30 | $5,609 | $175 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 39 | $5,461 | $65 |
| New patient visit (60+ min) | 28 | $5,446 | $194 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 347 | $4,742 | $13 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 58 | $3,765 | $64 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 47 | $3,509 | $75 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 43 | $2,705 | $63 |
| 3d radiographic procedure | 89 | $2,095 | $23 |
| Influenza vaccine split virus, preservative free | 27 | $1,762 | $65 |
| Ultrasound of heart, follow-up | 15 | $1,547 | $97 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 52 | $1,240 | $24 |
| Injection, perflutren lipid microspheres, per ml | 17 | $1,129 | $38 |
| Blood test, clotting time | 75 | $1,017 | $4 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 41 | $939 | $17 |
| 3d radiographic procedure with computerized image postprocessing | 12 | $851 | $71 |
| Heart rhythm recording of continous external ekg over 8-15 days | 52 | $782 | $15 |
| Administration of influenza virus vaccine | 28 | $591 | $21 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 19 | $529 | $26 |
2020: 25 services
| Return visit (30+ min) | 266 | $36,516 | $91 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 156 | $31,954 | $200 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 35 | $17,384 | $497 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 69 | $14,526 | $211 |
| Long return visit (40+ min) | 53 | $8,370 | $131 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 35 | $6,854 | $98 |
| Injection, regadenoson, 0.1 mg | 33 | $6,192 | None |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 32 | $5,937 | $186 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 32 | $5,601 | $67 |
| New patient visit (60+ min) | 24 | $4,737 | $197 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 293 | $4,531 | $15 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 43 | $3,587 | $82 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 45 | $3,088 | $67 |
| 3d radiographic procedure with computerized image postprocessing | 36 | $2,596 | $72 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 36 | $2,222 | $62 |
| Telephone medical discussion with physician, 21-30 minutes | 21 | $2,152 | $102 |
| Heart muscle strain imaging | 49 | $2,053 | $42 |
| Influenza vaccine split virus, preservative free | 33 | $1,991 | $60 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 40 | $1,460 | $22 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 51 | $1,285 | $25 |
| Blood test, clotting time | 87 | $1,193 | $4 |
| External ekg recording for more than 48 hours up to 21 days | 35 | $979 | $28 |
| Injection, perflutren lipid microspheres, per ml | 11 | $917 | $38 |
| Administration of influenza virus vaccine | 35 | $719 | $21 |
| 3d radiographic procedure | 14 | $305 | $22 |
2019: 25 services
| Return visit (30+ min) | 333 | $55,473 | $92 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 255 | $51,578 | $198 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 46 | $22,738 | $494 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 94 | $21,989 | $231 |
| New patient visit (60+ min) | 50 | $8,974 | $179 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 46 | $8,846 | $97 |
| Injection, regadenoson, 0.1 mg | 38 | $6,979 | None |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 399 | $6,213 | $14 |
| Long return visit (40+ min) | 40 | $6,137 | $133 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 28 | $5,642 | $182 |
| 3d radiographic procedure with computerized image postprocessing | 79 | $5,554 | $69 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 32 | $4,722 | $65 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 57 | $4,614 | $80 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 42 | $2,772 | $66 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 45 | $2,769 | $62 |
| Influenza vaccine split virus, preservative free | 33 | $1,779 | $54 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 52 | $1,637 | $20 |
| Ultrasound of heart, follow-up | 14 | $1,420 | $101 |
| Blood test, clotting time | 108 | $1,229 | $4 |
| External ekg recording for more than 48 hours up to 21 days | 44 | $1,194 | $27 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 44 | $1,053 | $23 |
| 3d radiographic procedure | 44 | $991 | $23 |
| Administration of influenza virus vaccine | 36 | $726 | $20 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 24 | $638 | $27 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 13 | $359 | $28 |
2018: 22 services
| Return visit (30+ min) | 285 | $45,252 | $95 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 196 | $40,285 | $204 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 34 | $17,172 | $505 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 63 | $14,333 | $228 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 35 | $7,021 | $180 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 34 | $6,488 | $95 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 42 | $5,821 | $65 |
| Long return visit (40+ min) | 35 | $5,229 | $128 |
| Injection, regadenoson, 0.1 mg | 29 | $5,141 | None |
| New patient visit (60+ min) | 23 | $4,304 | $187 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 263 | $4,264 | $15 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 49 | $3,296 | $66 |
| Transitional care management services for problem of high complexity | 13 | $3,067 | $219 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 34 | $2,820 | $83 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 36 | $2,186 | $61 |
| 3d radiographic procedure with computerized image postprocessing | 26 | $1,770 | $68 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 41 | $1,306 | $21 |
| Influenza vaccine split virus, preservative free | 19 | $838 | $44 |
| External ekg recording for more than 48 hours up to 21 days | 30 | $834 | $28 |
| Blood test, clotting time | 70 | $784 | $5 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 30 | $728 | $24 |
| Administration of influenza virus vaccine | 22 | $556 | $25 |
2017: 22 services
| Return visit (30+ min) | 342 | $56,449 | $86 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 255 | $56,049 | $217 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 140 | $36,328 | $256 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 23 | $11,228 | $488 |
| New patient visit (60+ min) | 60 | $10,052 | $168 |
| Critical care, first 30-74 minutes | 15 | $6,914 | $192 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 44 | $6,788 | $63 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 31 | $5,489 | $177 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 320 | $4,698 | $14 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 23 | $4,389 | $95 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 48 | $3,965 | $83 |
| Long return visit (40+ min) | 25 | $3,038 | $117 |
| Injection, regadenoson, 0.1 mg | 20 | $2,690 | None |
| New patient visit (45+ min) | 14 | $1,941 | $139 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 27 | $1,673 | $62 |
| External ekg recording for more than 48 hours up to 21 days | 45 | $1,260 | $28 |
| Blood test, clotting time | 84 | $1,162 | $5 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 45 | $1,097 | $24 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 36 | $1,003 | $17 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 12 | $994 | $83 |
| Influenza vaccine split virus, preservative free | 12 | $529 | $44 |
| Administration of influenza virus vaccine | 12 | $373 | $31 |
2016: 19 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 241 | $52,882 | $216 |
| Return visit (30+ min) | 305 | $52,242 | $92 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 101 | $25,454 | $252 |
| New patient visit (60+ min) | 127 | $22,035 | $174 |
| Short return visit (20+ min) | 178 | $13,279 | $49 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 38 | $7,824 | $174 |
| Critical care, first 30-74 minutes | 12 | $6,624 | $189 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 40 | $6,488 | $62 |
| Long return visit (40+ min) | 44 | $5,568 | $118 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 264 | $3,765 | $14 |
| New patient visit (45+ min) | 26 | $3,395 | $131 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 36 | $1,990 | $55 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 11 | $881 | $80 |
| Ultrasound of heart blood flow, valves and chambers | 13 | $695 | $53 |
| Blood test, clotting time | 49 | $383 | $5 |
| External ekg recording for more than 48 hours up to 21 days | 13 | $344 | $26 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 13 | $338 | $26 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 13 | $310 | $24 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 14 | $297 | $19 |
2015: 13 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 258 | $60,118 | $230 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 113 | $30,782 | $272 |
| Short return visit (20+ min) | 192 | $21,147 | $62 |
| Return visit (30+ min) | 155 | $21,013 | $92 |
| New patient visit (60+ min) | 98 | $18,172 | $185 |
| Critical care, first 30-74 minutes | 17 | $6,709 | $197 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 27 | $5,433 | $181 |
| Long return visit (40+ min) | 40 | $5,357 | $125 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 32 | $4,365 | $65 |
| Ultrasound of heart during rest, exercise and/or drug-induced stress with report | 15 | $3,808 | $254 |
| New patient visit (45+ min) | 20 | $2,954 | $148 |
| Transitional care management services for problem of high complexity | 12 | $2,629 | $219 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 17 | $939 | $55 |
2014: 9 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 179 | $40,290 | $225 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 89 | $24,920 | $277 |
| New patient visit (60+ min) | 88 | $15,204 | $173 |
| Short return visit (20+ min) | 130 | $13,319 | $63 |
| Return visit (30+ min) | 84 | $11,891 | $91 |
| Long return visit (40+ min) | 70 | $9,075 | $115 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 27 | $5,040 | $174 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 24 | $3,652 | $62 |
| New patient visit (45+ min) | 17 | $2,431 | $143 |
2013: 6 services
| Return visit (30+ min) | 88 | $10,397 | $93 |
| Short return visit (20+ min) | 90 | $8,035 | $67 |
| New patient visit (60+ min) | 31 | $5,564 | $179 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 33 | $4,416 | $134 |
| Long return visit (40+ min) | 31 | $4,321 | $131 |
| Removal of impacted ear wax | 11 | $532 | $48 |
Medicaid work
$54 in 2024
Medicaid paid $54 for 13 billed services this clinician did in 2024, up to 13 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 13 | $54 |
| 2024 | 13 | 1 | 13 | $54 |
| 2020 | 12 | 1 | 12 | $8 |
| 2019 | 37 | 1 | 13 | $62 |
See the largest Medicaid services in earlier years
2020
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 12 | $8 |
2019
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 37 | $62 |
Drugs they prescribed that Part D paid
$909,509
Pharmacies billed $909,509 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 5,393) in 2024. At or below the middle of the specialty; the typical cardiology clinician is at 0%.
4,726 generic and 667 brand-name prescriptions · $909,509 in drug cost · 23 antibiotic prescriptions to 13 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 345 | $508,733 | $1,475 |
| Jardiance | 69 | $106,964 | $1,550 |
| Entresto | 53 | $77,791 | $1,468 |
| Xarelto | 51 | $68,885 | $1,351 |
| Praluent | 33 | $28,576 | $866 |
See all 42 drugs
| Eliquis | 345 | $508,733 | $1,475 |
| Jardiance | 69 | $106,964 | $1,550 |
| Entresto | 53 | $77,791 | $1,468 |
| Xarelto | 51 | $68,885 | $1,351 |
| Praluent | 33 | $28,576 | $866 |
| Repatha Sureclick | 16 | $20,900 | $1,306 |
| Vascepa | 23 | $8,106 | $352 |
| Atorvastatin | 681 | $6,250 | $9 |
| Bisoprolol | 218 | $6,224 | $29 |
| Metoprolol | 403 | $5,918 | $15 |
| Rosuvastatin | 291 | $5,823 | $20 |
| Losartan | 434 | $4,814 | $11 |
| Valsartan | 92 | $3,919 | $43 |
| Amlodipine Besylate | 502 | $3,457 | $7 |
| Irbesartan | 66 | $2,324 | $35 |
| Carvedilol | 242 | $2,309 | $10 |
| Ezetimibe | 80 | $2,189 | $27 |
| Isosorbide Mononitrate Er | 107 | $2,004 | $19 |
| Hydralazine | 143 | $1,802 | $13 |
| Diltiazem 24hr Er (Cd) | 40 | $1,683 | $42 |
| Furosemide | 349 | $1,532 | $4 |
| Bumetanide | 24 | $1,524 | $64 |
| Spironolactone | 168 | $1,376 | $8 |
| Nitroglycerin | 55 | $1,273 | $23 |
| Bisoprolol-Hydrochlorothiazide | 41 | $1,190 | $29 |
| Clopidogrel | 78 | $1,084 | $14 |
| Digoxin | 37 | $916 | $25 |
| Doxazosin Mesylate | 70 | $868 | $12 |
| Lisinopril | 114 | $853 | $7 |
| Pravastatin | 49 | $816 | $17 |
| Hydrochlorothiazide | 118 | $628 | $5 |
| Verapamil Er | 17 | $598 | $35 |
| Olmesartan Medoxomil | 24 | $553 | $23 |
| Terazosin | 12 | $474 | $40 |
| Potassium Chloride | 17 | $371 | $22 |
| Chlorthalidone | 16 | $371 | $23 |
| Metoprolol | 27 | $310 | $11 |
| Benazepril | 18 | $206 | $11 |
| Pantoprazole | 16 | $169 | $11 |
| Metformin Hcl Er | 12 | $86 | $7 |
| Famotidine | 11 | $35 | $3 |
| Amoxicillin | 20 | $17 | $1 |
Year by year
| 2024 | 5,393 | 432 | 0% (0) | 12% | $909,509 |
| 2023 | 5,123 | 418 | 0% (0) | 10% | $844,773 |
| 2022 | 4,763 | 397 | 0% (0) | 10% | $647,519 |
| 2021 | 4,721 | 418 | 0% (0) | 9% | $527,787 |
| 2020 | 4,655 | 390 | 0% (0) | 10% | $449,037 |
| 2019 | 4,399 | 404 | 0% (0) | 11% | $449,199 |
| 2018 | 3,685 | 370 | 0% (0) | 13% | $326,756 |
| 2017 | 3,968 | 384 | 0% (0) | 18% | $321,738 |
| 2016 | 3,258 | 363 | 0% (0) | 20% | $226,925 |
| 2015 | 2,067 | 257 | 0% (0) | 22% | $106,131 |
| 2014 | 1,495 | 278 | None | None | $76,050 |
| 2013 | 1,255 | 235 | 4% (49) | None | $86,362 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 43 drugs
| Eliquis | 309 | $487,301 | $1,577 |
| Jardiance | 50 | $80,998 | $1,620 |
| Xarelto | 32 | $53,301 | $1,666 |
| Entresto | 23 | $43,695 | $1,900 |
| Praluent | 28 | $27,681 | $989 |
| Repatha Sureclick | 12 | $13,051 | $1,088 |
| Atorvastatin | 672 | $10,464 | $16 |
| Rosuvastatin | 271 | $8,744 | $32 |
| Losartan | 441 | $8,670 | $20 |
| Metoprolol | 389 | $8,067 | $21 |
| Bisoprolol | 202 | $7,207 | $36 |
| Amlodipine Besylate | 515 | $6,368 | $12 |
| Valsartan | 84 | $5,883 | $70 |
| Carvedilol | 273 | $5,372 | $20 |
| Icosapent Ethyl | 12 | $4,405 | $367 |
| Ezetimibe | 75 | $3,217 | $43 |
| Hydralazine | 151 | $3,054 | $20 |
| Bumetanide | 33 | $2,917 | $88 |
| Isosorbide Mononitrate Er | 112 | $2,839 | $25 |
| Nitroglycerin | 50 | $2,144 | $43 |
| Diltiazem 24hr Er (Cd) | 39 | $2,128 | $55 |
| Lisinopril | 134 | $1,904 | $14 |
| Furosemide | 232 | $1,751 | $8 |
| Spironolactone | 142 | $1,706 | $12 |
| Clopidogrel | 70 | $1,644 | $23 |
| Digoxin | 41 | $1,554 | $38 |
| Irbesartan | 30 | $1,422 | $47 |
| Bisoprolol-Hydrochlorothiazide | 36 | $1,246 | $35 |
| Potassium Chloride | 31 | $1,152 | $37 |
| Doxazosin Mesylate | 46 | $938 | $20 |
| Verapamil Er | 27 | $890 | $33 |
| Hydrochlorothiazide | 125 | $706 | $6 |
| Pravastatin | 46 | $703 | $15 |
| Olmesartan Medoxomil | 11 | $605 | $55 |
| Benazepril | 22 | $479 | $22 |
| Terazosin | 15 | $451 | $30 |
| Diltiazem 24hr Er | 13 | $414 | $32 |
| Pantoprazole | 20 | $379 | $19 |
| Clonidine | 19 | $294 | $15 |
| Metformin Hcl Er | 17 | $222 | $13 |
| Metoprolol | 20 | $168 | $8 |
| Warfarin | 11 | $85 | $8 |
| Amoxicillin | 17 | $21 | $1 |
2022: 39 drugs
| Eliquis | 282 | $435,515 | $1,544 |
| Xarelto | 23 | $36,961 | $1,607 |
| Entresto | 15 | $19,326 | $1,288 |
| Praluent | 15 | $18,729 | $1,249 |
| Jardiance | 12 | $18,332 | $1,528 |
| Rosuvastatin | 208 | $10,776 | $52 |
| Atorvastatin | 678 | $8,163 | $12 |
| Metoprolol | 389 | $7,901 | $20 |
| Losartan | 446 | $6,223 | $14 |
| Bisoprolol | 132 | $5,475 | $41 |
| Valsartan | 73 | $5,394 | $74 |
| Carvedilol | 253 | $4,948 | $20 |
| Amlodipine Besylate | 543 | $4,191 | $8 |
| Hydralazine | 157 | $3,984 | $25 |
| Isosorbide Mononitrate Er | 117 | $3,103 | $27 |
| Diltiazem 24hr Er (Cd) | 48 | $2,296 | $48 |
| Digoxin | 55 | $2,247 | $41 |
| Ezetimibe | 39 | $2,042 | $52 |
| Furosemide | 243 | $1,780 | $7 |
| Nitroglycerin | 50 | $1,766 | $35 |
| Potassium Chloride | 50 | $1,639 | $33 |
| Pravastatin | 74 | $1,366 | $18 |
| Spironolactone | 119 | $1,295 | $11 |
| Clopidogrel | 68 | $1,234 | $18 |
| Lisinopril | 134 | $1,225 | $9 |
| Irbesartan | 30 | $1,179 | $39 |
| Bumetanide | 11 | $1,113 | $101 |
| Bisoprolol-Hydrochlorothiazide | 20 | $644 | $32 |
| Hydrochlorothiazide | 93 | $642 | $7 |
| Verapamil Er | 22 | $610 | $28 |
| Pantoprazole | 23 | $405 | $18 |
| Olmesartan Medoxomil | 11 | $290 | $26 |
| Clonidine | 19 | $264 | $14 |
| Terazosin | 13 | $261 | $20 |
| Metformin Hcl Er | 20 | $247 | $12 |
| Fenofibrate | 11 | $203 | $18 |
| Losartan-Hydrochlorothiazide | 13 | $158 | $12 |
| Benazepril | 27 | $150 | $6 |
| Metoprolol | 26 | $143 | $6 |
2021: 38 drugs
| Eliquis | 271 | $380,334 | $1,403 |
| Xarelto | 15 | $18,980 | $1,265 |
| Atorvastatin | 646 | $10,461 | $16 |
| Metoprolol | 414 | $9,999 | $24 |
| Rosuvastatin | 205 | $8,121 | $40 |
| Valsartan | 80 | $7,673 | $96 |
| Losartan | 425 | $6,905 | $16 |
| Carvedilol | 285 | $4,745 | $17 |
| Bisoprolol | 83 | $4,734 | $57 |
| Hydralazine | 166 | $3,973 | $24 |
| Amlodipine Besylate | 520 | $3,861 | $7 |
| Isosorbide Mononitrate Er | 86 | $2,885 | $34 |
| Diltiazem 24hr Er (Cd) | 50 | $2,197 | $44 |
| Digoxin | 55 | $1,798 | $33 |
| Bumetanide | 18 | $1,612 | $90 |
| Furosemide | 265 | $1,570 | $6 |
| Ezetimibe | 31 | $1,533 | $49 |
| Clopidogrel | 95 | $1,470 | $15 |
| Potassium Chloride | 33 | $1,458 | $44 |
| Spironolactone | 109 | $1,404 | $13 |
| Nitroglycerin | 54 | $1,365 | $25 |
| Lisinopril | 171 | $1,350 | $8 |
| Pravastatin | 75 | $1,338 | $18 |
| Midodrine | 12 | $1,053 | $88 |
| Verapamil Er | 24 | $894 | $37 |
| Hydrochlorothiazide | 94 | $692 | $7 |
| Irbesartan | 25 | $673 | $27 |
| Pantoprazole | 36 | $673 | $19 |
| Doxazosin Mesylate | 22 | $515 | $23 |
| Cartia Xt | 15 | $424 | $28 |
| Losartan-Hydrochlorothiazide | 13 | $327 | $25 |
| Clonidine | 14 | $192 | $14 |
| Metformin Hcl Er | 20 | $176 | $9 |
| Metoprolol | 30 | $158 | $5 |
| Benazepril | 27 | $156 | $6 |
| Terazosin | 11 | $151 | $14 |
| Atenolol | 15 | $144 | $10 |
| Simvastatin | 17 | $70 | $4 |
2020: 38 drugs
| Eliquis | 245 | $294,617 | $1,203 |
| Xarelto | 33 | $32,469 | $984 |
| Atorvastatin | 682 | $12,436 | $18 |
| Metoprolol | 421 | $12,214 | $29 |
| Losartan | 411 | $7,244 | $18 |
| Rosuvastatin | 156 | $6,907 | $44 |
| Valsartan | 59 | $4,668 | $79 |
| Amlodipine Besylate | 496 | $4,328 | $9 |
| Carvedilol | 317 | $3,852 | $12 |
| Diltiazem 24hr Er (Cd) | 82 | $3,611 | $44 |
| Hydralazine | 121 | $3,205 | $26 |
| Isosorbide Mononitrate Er | 89 | $2,805 | $32 |
| Olmesartan Medoxomil | 22 | $2,749 | $125 |
| Potassium Chloride | 25 | $2,253 | $90 |
| Ezetimibe | 30 | $2,159 | $72 |
| Spironolactone | 146 | $1,896 | $13 |
| Clopidogrel | 105 | $1,804 | $17 |
| Digoxin | 36 | $1,732 | $48 |
| Lisinopril | 201 | $1,638 | $8 |
| Furosemide | 274 | $1,502 | $5 |
| Pravastatin | 53 | $1,401 | $26 |
| Bumetanide | 20 | $1,364 | $68 |
| Irbesartan | 34 | $1,362 | $40 |
| Losartan-Hydrochlorothiazide | 13 | $934 | $72 |
| Bisoprolol | 16 | $769 | $48 |
| Doxazosin Mesylate | 24 | $604 | $25 |
| Nitroglycerin | 44 | $600 | $14 |
| Cartia Xt | 12 | $590 | $49 |
| Hydrochlorothiazide | 69 | $556 | $8 |
| Pantoprazole | 33 | $505 | $15 |
| Verapamil Er | 14 | $392 | $28 |
| Warfarin | 22 | $339 | $15 |
| Atenolol | 27 | $263 | $10 |
| Metoprolol | 40 | $232 | $6 |
| Clonidine | 20 | $217 | $11 |
| Benazepril | 30 | $204 | $7 |
| Torsemide | 12 | $178 | $15 |
| Metformin Hcl Er | 15 | $135 | $9 |
2019: 38 drugs
| Eliquis | 237 | $249,685 | $1,054 |
| Xarelto | 46 | $47,779 | $1,039 |
| Praluent | 18 | $20,714 | $1,151 |
| Metoprolol | 431 | $15,734 | $37 |
| Atorvastatin | 634 | $12,476 | $20 |
| Rosuvastatin | 121 | $8,208 | $68 |
| Losartan | 358 | $5,431 | $15 |
| Carvedilol | 298 | $4,191 | $14 |
| Amlodipine Besylate | 423 | $3,834 | $9 |
| Diltiazem 24hr Er (Cd) | 73 | $3,297 | $45 |
| Valsartan | 46 | $2,960 | $64 |
| Isosorbide Mononitrate Er | 107 | $2,916 | $27 |
| Ezetimibe | 31 | $2,581 | $83 |
| Hydralazine | 105 | $2,529 | $24 |
| Olmesartan Medoxomil | 24 | $2,525 | $105 |
| Lisinopril | 232 | $2,006 | $9 |
| Spironolactone | 138 | $1,893 | $14 |
| Bumetanide | 17 | $1,796 | $106 |
| Furosemide | 233 | $1,592 | $7 |
| Nitroglycerin | 38 | $1,521 | $40 |
| Pravastatin | 48 | $1,441 | $30 |
| Clopidogrel | 71 | $1,245 | $18 |
| Irbesartan | 37 | $1,190 | $32 |
| Cartia Xt | 36 | $1,107 | $31 |
| Digoxin | 22 | $775 | $35 |
| Potassium Chloride | 18 | $691 | $38 |
| Hydrochlorothiazide | 73 | $643 | $9 |
| Metformin Hcl Er | 22 | $556 | $25 |
| Chlorthalidone | 14 | $497 | $35 |
| Warfarin | 29 | $411 | $14 |
| Metoprolol | 48 | $378 | $8 |
| Pantoprazole | 13 | $309 | $24 |
| Benazepril | 28 | $285 | $10 |
| Losartan-Hydrochlorothiazide | 21 | $247 | $12 |
| Atenolol | 21 | $181 | $9 |
| Fluticasone Propionate | 12 | $138 | $11 |
| Lovastatin | 15 | $126 | $8 |
| Torsemide | 12 | $99 | $8 |
2018: 36 drugs
| Eliquis | 179 | $166,561 | $931 |
| Xarelto | 27 | $27,526 | $1,019 |
| Praluent | 12 | $15,726 | $1,311 |
| Metoprolol | 359 | $14,224 | $40 |
| Atorvastatin | 552 | $11,367 | $21 |
| Rosuvastatin | 92 | $7,345 | $80 |
| Losartan | 375 | $4,832 | $13 |
| Isosorbide Mononitrate Er | 98 | $3,711 | $38 |
| Ezetimibe | 21 | $3,510 | $167 |
| Nitroglycerin | 33 | $3,164 | $96 |
| Amlodipine Besylate | 371 | $2,867 | $8 |
| Valsartan | 40 | $2,496 | $62 |
| Cartia Xt | 40 | $2,251 | $56 |
| Carvedilol | 217 | $2,115 | $10 |
| Hydralazine | 80 | $1,648 | $21 |
| Lisinopril | 190 | $1,646 | $9 |
| Diltiazem 24hr Er (Cd) | 36 | $1,555 | $43 |
| Pravastatin | 42 | $1,420 | $34 |
| Furosemide | 202 | $1,271 | $6 |
| Potassium Chloride | 36 | $1,197 | $33 |
| Spironolactone | 83 | $1,160 | $14 |
| Fenofibrate | 11 | $1,113 | $101 |
| Clopidogrel | 46 | $851 | $19 |
| Digoxin | 16 | $792 | $50 |
| Dilt-Xr | 12 | $598 | $50 |
| Hydrochlorothiazide | 60 | $524 | $9 |
| Warfarin | 41 | $521 | $13 |
| Irbesartan | 16 | $332 | $21 |
| Metoprolol | 37 | $277 | $7 |
| Benazepril | 22 | $267 | $12 |
| Pantoprazole | 14 | $263 | $19 |
| Metformin Hcl Er | 17 | $211 | $12 |
| Losartan-Hydrochlorothiazide | 14 | $175 | $12 |
| Simvastatin | 21 | $164 | $8 |
| Atenolol | 20 | $143 | $7 |
| Lovastatin | 11 | $89 | $8 |
2017: 39 drugs
| Eliquis | 163 | $142,916 | $877 |
| Xarelto | 37 | $32,936 | $890 |
| Metoprolol | 367 | $15,136 | $41 |
| Repatha Sureclick | 11 | $12,472 | $1,134 |
| Atorvastatin | 558 | $12,035 | $22 |
| Brilinta | 13 | $7,076 | $544 |
| Zetia | 11 | $5,923 | $538 |
| Rosuvastatin | 60 | $5,832 | $97 |
| Losartan | 475 | $4,942 | $10 |
| Ezetimibe | 22 | $3,889 | $177 |
| Isosorbide Mononitrate Er | 120 | $3,806 | $32 |
| Nitroglycerin | 26 | $3,444 | $132 |
| Amlodipine Besylate | 366 | $2,709 | $7 |
| Valsartan | 58 | $2,495 | $43 |
| Olmesartan Medoxomil | 14 | $2,281 | $163 |
| Potassium Chloride | 55 | $2,224 | $40 |
| Cartia Xt | 43 | $1,957 | $46 |
| Hydralazine | 106 | $1,922 | $18 |
| Carvedilol | 206 | $1,893 | $9 |
| Furosemide | 222 | $1,437 | $6 |
| Diltiazem 24hr Er | 35 | $1,395 | $40 |
| Lisinopril | 169 | $1,207 | $7 |
| Spironolactone | 75 | $1,107 | $15 |
| Digoxin | 17 | $1,016 | $60 |
| Chlorthalidone | 15 | $975 | $65 |
| Warfarin | 66 | $957 | $15 |
| Clopidogrel | 57 | $932 | $16 |
| Fenofibrate | 13 | $917 | $71 |
| Pravastatin | 25 | $851 | $34 |
| Hydrochlorothiazide | 104 | $718 | $7 |
| Metoprolol | 69 | $498 | $7 |
| Dilt-Xr | 17 | $374 | $22 |
| Benazepril | 24 | $248 | $10 |
| Atenolol | 26 | $220 | $8 |
| Metformin Hcl Er | 18 | $166 | $9 |
| Simvastatin | 22 | $161 | $7 |
| Triamterene-Hydrochlorothiazid | 12 | $119 | $10 |
| Losartan-Hydrochlorothiazide | 11 | $109 | $10 |
| Lovastatin | 12 | $106 | $9 |
2016: 35 drugs
| Eliquis | 113 | $80,249 | $710 |
| Xarelto | 47 | $26,962 | $574 |
| Atorvastatin | 460 | $11,478 | $25 |
| Metoprolol | 321 | $10,765 | $34 |
| Zetia | 29 | $9,202 | $317 |
| Valsartan | 46 | $6,390 | $139 |
| Benicar | 11 | $6,159 | $560 |
| Potassium Chloride | 82 | $4,405 | $54 |
| Losartan | 413 | $4,392 | $11 |
| Isosorbide Mononitrate Er | 133 | $3,563 | $27 |
| Amlodipine Besylate | 278 | $2,405 | $9 |
| Cartia Xt | 43 | $1,661 | $39 |
| Carvedilol | 154 | $1,446 | $9 |
| Diltiazem 24hr Er | 26 | $1,426 | $55 |
| Eplerenone | 11 | $1,420 | $129 |
| Chlorthalidone | 23 | $1,258 | $55 |
| Hydralazine | 58 | $1,080 | $19 |
| Spironolactone | 74 | $1,036 | $14 |
| Lisinopril | 117 | $978 | $8 |
| Furosemide | 173 | $945 | $5 |
| Digoxin | 17 | $865 | $51 |
| Warfarin | 62 | $838 | $14 |
| Clopidogrel | 31 | $589 | $19 |
| Metoprolol | 55 | $528 | $10 |
| Pravastatin | 16 | $484 | $30 |
| Nitrostat | 20 | $473 | $24 |
| Hydrochlorothiazide | 48 | $402 | $8 |
| Omeprazole | 24 | $384 | $16 |
| Benazepril | 26 | $213 | $8 |
| Fluticasone Propionate | 21 | $201 | $10 |
| Clonidine | 15 | $155 | $10 |
| Atenolol | 35 | $147 | $4 |
| Losartan-Hydrochlorothiazide | 11 | $117 | $11 |
| Lovastatin | 11 | $82 | $7 |
| Simvastatin | 14 | $75 | $5 |
2015: 31 drugs
| Eliquis | 40 | $23,394 | $585 |
| Xarelto | 31 | $17,158 | $553 |
| Metoprolol | 170 | $8,006 | $47 |
| Atorvastatin | 308 | $7,692 | $25 |
| Crestor | 16 | $5,061 | $316 |
| Potassium Chloride | 79 | $3,327 | $42 |
| Valsartan | 18 | $3,124 | $174 |
| Zetia | 12 | $2,817 | $235 |
| Losartan | 211 | $2,299 | $11 |
| Isosorbide Mononitrate Er | 48 | $1,304 | $27 |
| Chlorthalidone | 28 | $1,069 | $38 |
| Pravastatin | 23 | $1,034 | $45 |
| Amlodipine Besylate | 151 | $969 | $6 |
| Hydralazine | 35 | $793 | $23 |
| Furosemide | 135 | $750 | $6 |
| Lisinopril | 115 | $750 | $7 |
| Carvedilol | 83 | $705 | $8 |
| Warfarin | 41 | $523 | $13 |
| Cartia Xt | 11 | $483 | $44 |
| Diltiazem 24hr Cd | 19 | $459 | $24 |
| Clopidogrel | 30 | $437 | $15 |
| Nitrostat | 30 | $430 | $14 |
| Triamterene-Hydrochlorothiazid | 22 | $430 | $20 |
| Spironolactone | 48 | $415 | $9 |
| Omeprazole | 21 | $330 | $16 |
| Metoprolol | 48 | $296 | $6 |
| Atenolol | 33 | $200 | $6 |
| Hydrochlorothiazide | 23 | $188 | $8 |
| Simvastatin | 27 | $174 | $6 |
| Clonidine | 16 | $145 | $9 |
| Benazepril | 15 | $86 | $6 |
2014: 31 drugs
| Xarelto | 20 | $11,365 | $568 |
| Atorvastatin | 193 | $5,360 | $28 |
| Diovan | 19 | $5,155 | $271 |
| Flovent Hfa | 16 | $3,078 | $192 |
| Metoprolol | 48 | $2,726 | $57 |
| Potassium Chloride | 62 | $2,314 | $37 |
| Losartan | 121 | $1,497 | $12 |
| Lisinopril | 87 | $811 | $9 |
| Pravastatin | 19 | $793 | $42 |
| Amlodipine Besylate | 98 | $714 | $7 |
| Omeprazole | 48 | $683 | $14 |
| Losartan-Hydrochlorothiazide | 13 | $565 | $43 |
| Carvedilol | 36 | $426 | $12 |
| Metformin | 29 | $425 | $15 |
| Isosorbide Mononitrate Er | 20 | $374 | $19 |
| Simvastatin | 39 | $369 | $9 |
| Clopidogrel | 22 | $366 | $17 |
| Levothyroxine | 13 | $360 | $28 |
| Furosemide | 70 | $333 | $5 |
| Fluticasone Propionate | 22 | $331 | $15 |
| Hydrochlorothiazide | 30 | $330 | $11 |
| Metoprolol | 42 | $313 | $7 |
| Nitrostat | 20 | $251 | $13 |
| Spironolactone | 20 | $244 | $12 |
| Prazosin | 13 | $231 | $18 |
| Clonidine | 12 | $195 | $16 |
| Warfarin | 24 | $191 | $8 |
| Triamterene-Hydrochlorothiazid | 14 | $189 | $13 |
| Benazepril | 20 | $170 | $8 |
| Atenolol | 18 | $150 | $8 |
| Alendronate | 13 | $86 | $7 |
2013: 29 drugs
| Diovan | 25 | $8,218 | $329 |
| Benicar | 24 | $4,049 | $169 |
| Flovent Hfa | 12 | $2,466 | $206 |
| Atorvastatin | 63 | $1,969 | $31 |
| Escitalopram | 20 | $1,037 | $52 |
| Fluticasone Propionate | 31 | $952 | $31 |
| Losartan | 52 | $942 | $18 |
| Proair Hfa | 12 | $731 | $61 |
| Metformin | 52 | $675 | $13 |
| Estradiol | 12 | $663 | $55 |
| Potassium Chloride | 16 | $661 | $41 |
| Omeprazole | 31 | $576 | $19 |
| Levothyroxine | 36 | $569 | $16 |
| Amlodipine Besylate | 54 | $552 | $10 |
| Simvastatin | 52 | $509 | $10 |
| Lovastatin | 22 | $487 | $22 |
| Synthroid | 12 | $396 | $33 |
| Alendronate | 25 | $370 | $15 |
| Lisinopril | 44 | $311 | $7 |
| Gabapentin | 15 | $310 | $21 |
| Pravastatin | 13 | $287 | $22 |
| Benazepril-Hydrochlorothiazide | 12 | $253 | $21 |
| Hydrocodone-Acetaminophen | 30 | $242 | $8 |
| Lorazepam | 24 | $233 | $10 |
| Hydrochlorothiazide | 24 | $206 | $9 |
| Metformin Hcl Er | 13 | $191 | $15 |
| Benazepril | 47 | $181 | $4 |
| Digox | 12 | $138 | $11 |
| Buspirone | 12 | $124 | $10 |
Professional record
- NPI
- 1275683286
- Licence
- CA A97154California A97154: Current · expires 2028-01-31
- Trained
- University of California, Davis School of Medicine, 2005
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Cardiology (207RC0000X); Internal medicine (207R00000X)
- Mailing address
- 325 Distel Cir, Los Altos, CA, 94022
- NPI first listed
- 2007-01-11
- NPI last updated
- 2020-05-28
- NPI record certified
- 2020-05-28
This is when the NPI record was last certified, not a medical board exam.